Oireachtas Joint and Select Committees
Wednesday, 6 March 2019
Joint Oireachtas Committee on Health
National Medicines Strategy: Discussion
Dr. Kieran Harkin:
Absolutely. It is not reimbursed nor has the person who put in the money upfront got any input into price or transparency. If one asks how much the drug cost or where the funding came from, one is told it is not his or her concern. The funder has no rights once the product is passed on.
No comments